Four Months And Ticking: No New Opinions From EU Medtech Expert Panels
The EU expert panels set up to support the review of high-risk products had produced three opinions on medical devices and 15 “views” on IVDs by the start of March. Nothing has been published since.
You may also be interested in...
The highest risk IVDs are due to receive an extra layer of regulatory scrutiny in the EU. But it is taking a long time to set up the structures needed.
While each new designation of a notified bodies in the medtech space is good news, many more organizations are needed rapidly to help manage growing demand. Capacity warnings continue.
The first seven months of 2022 have seen significant progress on documents, tools and new structures needed for the MDR and IVDR implementation. But with major hurdles ahead, in July it was still the problems and not the successes taking centre stage